首页 > 最新文献

Journal of Basic and Clinical Pharmacy最新文献

英文 中文
A survey on medicines safety and usage in community pharmacy. 社区药房药品安全与使用情况调查。
Pub Date : 2013-12-01 DOI: 10.4103/0976-0105.128254
Varsha A Prabhu, Vaishnavi Naik, Sahiti Doddapaneni, Uday Venkat Mateti, Anantha Naik Nagappa
Medicines are important agent in curing the several diseases of the patient by lowering the signs and symptoms through different mechanism. If the medicines, are over used, under used and misused leads to therapeutically ineffectiveness and adverse drug reactions.[1] In the developing countries, there is huge demand for creating the awareness regarding irrational use of medicines, which can prevent the unwanted effects of the medicine also self‐medication is another issue which has become more common especially for over‐the‐counter medications and also factors such as socio‐economic status, satisfaction of the patient, gender etc., which has led to several interactions and adverse drug reaction due to the lack of knowledge on drugs.[2] Drugs like antibiotic proven to be of higher resistance due to improper prescribing and usage are being self‐medicated without the exact knowledge leading to morbidity and mortality.[3]
{"title":"A survey on medicines safety and usage in community pharmacy.","authors":"Varsha A Prabhu, Vaishnavi Naik, Sahiti Doddapaneni, Uday Venkat Mateti, Anantha Naik Nagappa","doi":"10.4103/0976-0105.128254","DOIUrl":"https://doi.org/10.4103/0976-0105.128254","url":null,"abstract":"Medicines are important agent in curing the several diseases of the patient by lowering the signs and symptoms through different mechanism. If the medicines, are over used, under used and misused leads to therapeutically ineffectiveness and adverse drug reactions.[1] In the developing countries, there is huge demand for creating the awareness regarding irrational use of medicines, which can prevent the unwanted effects of the medicine also self‐medication is another issue which has become more common especially for over‐the‐counter medications and also factors such as socio‐economic status, satisfaction of the patient, gender etc., which has led to several interactions and adverse drug reaction due to the lack of knowledge on drugs.[2] Drugs like antibiotic proven to be of higher resistance due to improper prescribing and usage are being self‐medicated without the exact knowledge leading to morbidity and mortality.[3]","PeriodicalId":15046,"journal":{"name":"Journal of Basic and Clinical Pharmacy","volume":"5 1","pages":"24-5"},"PeriodicalIF":0.0,"publicationDate":"2013-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4103/0976-0105.128254","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32324964","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Assessment of medication adherence in type-2 diabetes patients on poly pharmacy and the effect of patient counseling given to them in a multispecialty hospital. 多专科医院2型糖尿病患者多药房用药依从性评价及患者咨询效果
Pub Date : 2013-12-01 DOI: 10.4103/0976-0105.128251
Elizabeth Mampally Mathew, Kingston Rajiah

Introduction: The ability of physicians to recognize non-adherence is poor and interventions to improve adherence have had mixed results. Furthermore, successful interventions generally are substantially complex and costly. Poor adherence to medication regimens accounts for substantial worsening of disease; death and increased health care costs. The aim of this study is to assess the medication adherence in type-2 diabetes patients who are on polypharmacy and the effect of counseling provided for them in a multispecialty hospital.

Materials and methods: The study was carried out at Kovai Medical Center and Hospital; Coimbatore Tamil Nadu, India. This is a 500-bedded modernized, multi-specialty tertiary care hospital with full-fledged diabetic department. It caters to the needs of both out-patients and in-patients. An assessment was made on type-2 diabetic patients who are receiving more than 5 drugs for their co-morbidities were included in this study. A medication adherence questionnaire was prepared based on the literatures. The study was approved by the Kovai Medical Center and Hospital ethics committee.

Results: Among 240 patients, 124 patients were adherent to medication whereas 116 patients were non-adherent. The non-adherent patients were giving verbal counseling in a private counseling room regarding medication adherence.

Conclusions: Best way health professionals can tackle the adherence problem is through quality patient counseling as done in this study. With limited time most professionals have with a patient today this can be easier said than done. However, techniques such as the ask-educate-ask approach, the teach-back method and motivational interviewing can help ensure patient understanding of the counseling provided.

引言:医生识别不依从性的能力很差,改善依从性的干预措施有不同的结果。此外,成功的干预措施通常相当复杂和昂贵。不遵守药物治疗方案是疾病严重恶化的原因;死亡和医疗费用增加。本研究的目的是评估综合用药的2型糖尿病患者的药物依从性以及在多专科医院为他们提供咨询的效果。材料与方法:本研究在科凯医学中心医院进行;哥印拜陀,印度泰米尔纳德邦。这是一所拥有500张床位的现代化多专科三级医院,拥有完善的糖尿病科。它既满足门诊病人的需要,也满足住院病人的需要。评估2型糖尿病患者同时接受5种以上药物治疗的合并症。根据文献编制药物依从性问卷。该研究得到了kowai医疗中心和医院伦理委员会的批准。结果:240例患者中,124例患者坚持用药,116例患者不坚持用药。非依从性患者在私人咨询室接受关于药物依从性的口头咨询。结论:卫生专业人员解决依从性问题的最佳方法是通过本研究中所做的高质量患者咨询。由于今天大多数专业人员与病人相处的时间有限,这说起来容易做起来难。然而,诸如问-教育-问方法、教-回方法和动机性访谈等技术可以帮助确保患者理解所提供的咨询。
{"title":"Assessment of medication adherence in type-2 diabetes patients on poly pharmacy and the effect of patient counseling given to them in a multispecialty hospital.","authors":"Elizabeth Mampally Mathew,&nbsp;Kingston Rajiah","doi":"10.4103/0976-0105.128251","DOIUrl":"https://doi.org/10.4103/0976-0105.128251","url":null,"abstract":"<p><strong>Introduction: </strong>The ability of physicians to recognize non-adherence is poor and interventions to improve adherence have had mixed results. Furthermore, successful interventions generally are substantially complex and costly. Poor adherence to medication regimens accounts for substantial worsening of disease; death and increased health care costs. The aim of this study is to assess the medication adherence in type-2 diabetes patients who are on polypharmacy and the effect of counseling provided for them in a multispecialty hospital.</p><p><strong>Materials and methods: </strong>The study was carried out at Kovai Medical Center and Hospital; Coimbatore Tamil Nadu, India. This is a 500-bedded modernized, multi-specialty tertiary care hospital with full-fledged diabetic department. It caters to the needs of both out-patients and in-patients. An assessment was made on type-2 diabetic patients who are receiving more than 5 drugs for their co-morbidities were included in this study. A medication adherence questionnaire was prepared based on the literatures. The study was approved by the Kovai Medical Center and Hospital ethics committee.</p><p><strong>Results: </strong>Among 240 patients, 124 patients were adherent to medication whereas 116 patients were non-adherent. The non-adherent patients were giving verbal counseling in a private counseling room regarding medication adherence.</p><p><strong>Conclusions: </strong>Best way health professionals can tackle the adherence problem is through quality patient counseling as done in this study. With limited time most professionals have with a patient today this can be easier said than done. However, techniques such as the ask-educate-ask approach, the teach-back method and motivational interviewing can help ensure patient understanding of the counseling provided.</p>","PeriodicalId":15046,"journal":{"name":"Journal of Basic and Clinical Pharmacy","volume":"5 1","pages":"15-8"},"PeriodicalIF":0.0,"publicationDate":"2013-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4103/0976-0105.128251","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32324962","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 22
Drug utilization patterns in the emergency department: A retrospective study. 急诊科药物使用模式的回顾性研究
Pub Date : 2013-12-01 DOI: 10.4103/0976-0105.128226
K A Al Balushi, S Al-Shibli, I Al-Zakwani

Objectives: The aim of this study was to assess the prescribing trends and costs of drugs in the emergency department (ED) at Sultan Qaboos University Hospital (SQUH), a tertiary care hospital, in Muscat, the Sultanate of Oman.

Materials and methods: This was a retrospective cross-sectional study of all patients (n = 300) who attended the ED at SQUH in May 2012. Analyses were performed using descriptive and univariate statistics.

Results: The average age of patients was 34 ± 19 years. The average number of drugs prescribed per patients was 3.2 ± 1.9 and the majority of the patients (n = 78; 26%) received two drugs. The most common route of drug administration was the oral route (n = 481; 51%) followed by parenterally (n = 357; 38%). Non-steroidal anti-inflammatory drugs (NSAIDs) were the most commonly prescribed class of drugs (38%) followed by the gastro-intestinal tract drugs (19%) and central nervous system drugs (13%). The average cost per prescription was 242 ± 632 US$. Morphine had the highest cost (1885 US$) followed by cefuroxime (1404 US$) and filgrastim (939 US$) over the 1-month period. There was a significant positive correlation between hospital cost and age (P < 0.001), duration of stay at the ED (P = 0.008) and emergency types (P < 0.001).

Conclusion: NSAIDs were the most frequent class of drugs administered to patients. Highest number of drugs was prescribed for cardiovascular diseases followed by respiratory and gastrointestinal diseases. Anti-infective drugs cost was the highest among all other classes. The results of the present study are attempts to highlight the importance of strategies that have to be implemented to optimize medication use at the ED.

目的:本研究的目的是评估阿曼苏丹国马斯喀特的三级保健医院苏丹卡布斯大学医院(SQUH)急诊科(ED)的处方趋势和药物费用。材料和方法:这是一项回顾性横断面研究,纳入2012年5月在SQUH急诊科就诊的所有患者(n = 300)。采用描述性和单变量统计进行分析。结果:患者平均年龄34±19岁。平均每例患者处方药物数为3.2±1.9,绝大多数患者(n = 78;26%)接受两种药物治疗。最常见的给药途径是口服给药(n = 481;51%),其次是肠外注射(n = 357;38%)。非甾体类抗炎药(NSAIDs)是最常用的处方类药物(38%),其次是胃肠道药物(19%)和中枢神经系统药物(13%)。每张处方的平均费用为242±632美元。1个月的用药成本以吗啡最高(1885美元),其次是头孢呋辛(1404美元)和非格拉西汀(939美元)。住院费用与年龄(P < 0.001)、急诊科住院时间(P = 0.008)和急诊类型(P < 0.001)呈正相关。结论:非甾体抗炎药是患者最常用的药物。用于心血管疾病的药物数量最多,其次是呼吸道疾病和胃肠道疾病。在所有类别中,抗感染药物的费用最高。本研究的结果是试图强调必须实施的策略的重要性,以优化急诊科的药物使用。
{"title":"Drug utilization patterns in the emergency department: A retrospective study.","authors":"K A Al Balushi,&nbsp;S Al-Shibli,&nbsp;I Al-Zakwani","doi":"10.4103/0976-0105.128226","DOIUrl":"https://doi.org/10.4103/0976-0105.128226","url":null,"abstract":"<p><strong>Objectives: </strong>The aim of this study was to assess the prescribing trends and costs of drugs in the emergency department (ED) at Sultan Qaboos University Hospital (SQUH), a tertiary care hospital, in Muscat, the Sultanate of Oman.</p><p><strong>Materials and methods: </strong>This was a retrospective cross-sectional study of all patients (n = 300) who attended the ED at SQUH in May 2012. Analyses were performed using descriptive and univariate statistics.</p><p><strong>Results: </strong>The average age of patients was 34 ± 19 years. The average number of drugs prescribed per patients was 3.2 ± 1.9 and the majority of the patients (n = 78; 26%) received two drugs. The most common route of drug administration was the oral route (n = 481; 51%) followed by parenterally (n = 357; 38%). Non-steroidal anti-inflammatory drugs (NSAIDs) were the most commonly prescribed class of drugs (38%) followed by the gastro-intestinal tract drugs (19%) and central nervous system drugs (13%). The average cost per prescription was 242 ± 632 US$. Morphine had the highest cost (1885 US$) followed by cefuroxime (1404 US$) and filgrastim (939 US$) over the 1-month period. There was a significant positive correlation between hospital cost and age (P < 0.001), duration of stay at the ED (P = 0.008) and emergency types (P < 0.001).</p><p><strong>Conclusion: </strong>NSAIDs were the most frequent class of drugs administered to patients. Highest number of drugs was prescribed for cardiovascular diseases followed by respiratory and gastrointestinal diseases. Anti-infective drugs cost was the highest among all other classes. The results of the present study are attempts to highlight the importance of strategies that have to be implemented to optimize medication use at the ED.</p>","PeriodicalId":15046,"journal":{"name":"Journal of Basic and Clinical Pharmacy","volume":"5 1","pages":"1-6"},"PeriodicalIF":0.0,"publicationDate":"2013-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4103/0976-0105.128226","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32323958","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 25
The examination of geriatric pharmacotherapy. 老年药物治疗的研究。
Pub Date : 2013-09-01 DOI: 10.4103/0976-0105.121648
Abimbola Farinde
Address for correspondence: Dr. Abimbola Farinde, Clear Lake Regional Medical Center, Webster, Texas 77598, USA. E-mail: aofpharm420@hotmail.com The geriatric population can be viewed by the medical and scientific community as a particularly unique patient population given the age related changes that can occur over time which can contribute to mental, biologic deterioration, or psychological failures that can impair functionality.[1] In the United States, the approximate estimation was that less than 15% of the total population was older than 65 years of age in 2004, and this number is expected to increase to 20% by 2030.[2] As a result of age related impairments, the older population can be placed on a number of pharmacological agents in an attempt to maintain or improve the quality of life, or extend functional ability to a certain degree. The primary goal of geriatric pharmacotherapy is centered on optimizing drug treatment which can provide to be difficult given the lack of age-specific guidelines or scientific evidence in this age group to inform clinical decision making.[3,4]
{"title":"The examination of geriatric pharmacotherapy.","authors":"Abimbola Farinde","doi":"10.4103/0976-0105.121648","DOIUrl":"https://doi.org/10.4103/0976-0105.121648","url":null,"abstract":"Address for correspondence: Dr. Abimbola Farinde, Clear Lake Regional Medical Center, Webster, Texas 77598, USA. E-mail: aofpharm420@hotmail.com The geriatric population can be viewed by the medical and scientific community as a particularly unique patient population given the age related changes that can occur over time which can contribute to mental, biologic deterioration, or psychological failures that can impair functionality.[1] In the United States, the approximate estimation was that less than 15% of the total population was older than 65 years of age in 2004, and this number is expected to increase to 20% by 2030.[2] As a result of age related impairments, the older population can be placed on a number of pharmacological agents in an attempt to maintain or improve the quality of life, or extend functional ability to a certain degree. The primary goal of geriatric pharmacotherapy is centered on optimizing drug treatment which can provide to be difficult given the lack of age-specific guidelines or scientific evidence in this age group to inform clinical decision making.[3,4]","PeriodicalId":15046,"journal":{"name":"Journal of Basic and Clinical Pharmacy","volume":"4 4","pages":"76-7"},"PeriodicalIF":0.0,"publicationDate":"2013-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a4/ce/JBCP-4-76.PMC3979267.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32323953","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bipolar disorder: A brief examination of lithium therapy. 双相情感障碍:锂治疗的简要检查。
Pub Date : 2013-09-01 DOI: 10.4103/0976-0105.121656
Abimbola Farinde
Address for correspondence: Dr. Abimbola Farinde Department of Pharmacy, Clear Lake Regional Medical Center, Webster, Texas, USA. E-mail: aofpharm420@hotmail.com Within the 21st century, bipolar I disorder (BD-I) has become a clinically significant and recognizable mental illness comparable to schizophrenia and depression but more evidenced based research is still needed to fully understand the mechanism of the disorder.[1] While bipolar disorder is becoming an increasing prevalent disorder in the general public, it can often be misdiagnosed with poor symptomatic and psychosocial outcomes even after treatment initiation.[1,2] The problem can lie in the fact that most bipolar patients can remain hidden for years unaware of their diagnosis or may be falsely diagnosed as suffering a similar or comparable mental illness.[2] There may be a significant delay between the first experience of symptoms and the initiation of symptoms which can be as long as 8–9 years.[3,4] The pristine presentation of the symptoms of bipolar disorder can be viewed as the exception rather than the rule due to the fact that the majority of patients can experience psychiatric comorbidity or one-third will experience rapid cycling at some point in their illness, thus providing a complex presentation and treatment.[5,6] Even though complex bipolar disorders are becoming increasingly more widespread, clinicians long relied on the description of symptom presentation as listed in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR).[6,7] The diagnosis of bipolar disorder should consist of a diagnostic differentiation using the combination of psychological, cognitive, and behavioral symptomatology and assessment of the clinical course of the illness.[8] The dramatic growth in the rate of bipolar disorder diagnosis during the last decade both in clinical and research setting has enhanced clinicians’ understanding of ways to provide effective and optimal therapeutic interventions for this lifelong affective disorder.[9]
{"title":"Bipolar disorder: A brief examination of lithium therapy.","authors":"Abimbola Farinde","doi":"10.4103/0976-0105.121656","DOIUrl":"https://doi.org/10.4103/0976-0105.121656","url":null,"abstract":"Address for correspondence: Dr. Abimbola Farinde Department of Pharmacy, Clear Lake Regional Medical Center, Webster, Texas, USA. E-mail: aofpharm420@hotmail.com Within the 21st century, bipolar I disorder (BD-I) has become a clinically significant and recognizable mental illness comparable to schizophrenia and depression but more evidenced based research is still needed to fully understand the mechanism of the disorder.[1] While bipolar disorder is becoming an increasing prevalent disorder in the general public, it can often be misdiagnosed with poor symptomatic and psychosocial outcomes even after treatment initiation.[1,2] The problem can lie in the fact that most bipolar patients can remain hidden for years unaware of their diagnosis or may be falsely diagnosed as suffering a similar or comparable mental illness.[2] There may be a significant delay between the first experience of symptoms and the initiation of symptoms which can be as long as 8–9 years.[3,4] The pristine presentation of the symptoms of bipolar disorder can be viewed as the exception rather than the rule due to the fact that the majority of patients can experience psychiatric comorbidity or one-third will experience rapid cycling at some point in their illness, thus providing a complex presentation and treatment.[5,6] Even though complex bipolar disorders are becoming increasingly more widespread, clinicians long relied on the description of symptom presentation as listed in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR).[6,7] The diagnosis of bipolar disorder should consist of a diagnostic differentiation using the combination of psychological, cognitive, and behavioral symptomatology and assessment of the clinical course of the illness.[8] The dramatic growth in the rate of bipolar disorder diagnosis during the last decade both in clinical and research setting has enhanced clinicians’ understanding of ways to provide effective and optimal therapeutic interventions for this lifelong affective disorder.[9]","PeriodicalId":15046,"journal":{"name":"Journal of Basic and Clinical Pharmacy","volume":"4 4","pages":"93-4"},"PeriodicalIF":0.0,"publicationDate":"2013-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/79/da/JBCP-4-93.PMC3979269.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32323957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Drug utilization in emergency medicine department at a tertiary care teaching hospital: A prospective study. 某三级教学医院急诊科药物利用的前瞻性研究。
Pub Date : 2013-09-01 DOI: 10.4103/0976-0105.121650
Preksha A Barot, Supriya D Malhotra, Devang A Rana, Varsha J Patel, Kamlesh P Patel

Background and objectives: The practice of emergency medicine has the primary mission of evaluating, managing and providing treatment to those patients with unexpected injury or illness. Instituting appropriate therapy is necessary for safety of the patients and to decrease mortality and morbidity. The objectives were to study the drug utilization pattern and direct cost of therapy in emergency medicine department of a tertiary care teaching hospital.

Materials and methods: Data of the patients admitted to emergency medicine department was collected prospectively for 48 h from the time of admission over 2 months. The prescriptions were analyzed for drug use pattern and direct cost of therapy was calculated.

Results: A total of 156 patients received 1635 drugs with the mean of 9.99 ± 2.55 drugs/patient. Most common diagnosis was acute coronary syndrome 35 (21.79%). Ondansetron 135 (86.53%) was most frequently prescribed drug followed by pantoprazole 133 (85.25%) and furosemide 68 (43.58%). Amongst antimicrobials ceftriaxone 51 (32.69%) was the most commonly prescribed drug. Direct cost of treatment per patient for the first 48 h was र 4051 ± 1641.

Conclusion: Ondansetron and pantoprazole were the most commonly prescribed drugs in the emergency department. However, their use in all patients was not justified. Polypharmacy was prevalent. A closer look at the rationality of therapy would help in highlighting issues involved and would be helpful to authorities in deciding prescribing policies.

背景和目的:急诊医学实践的主要任务是评估、管理和提供治疗那些意外伤害或疾病的患者。制定适当的治疗方法对于患者的安全以及降低死亡率和发病率是必要的。目的探讨某三级教学医院急诊科的药物利用模式及治疗直接费用。材料与方法:前瞻性收集急诊医学科收治患者自入院后2个月内48 h的资料。分析处方用药方式,计算直接治疗费用。结果156例患者共使用药物1635种,平均(9.99±2.55)种/例。最常见的诊断是急性冠脉综合征35(21.79%)。用药最多的是昂丹司琼135(86.53%),其次是泮托拉唑133(85.25%)和呋塞米68(43.58%)。在抗菌药物中,头孢曲松51(32.69%)是最常用的处方药物。每位患者前48小时的直接治疗成本为4051±1641。结论:昂丹司琼和泮托拉唑是急诊科最常用的药物。然而,它们在所有患者中的应用并不合理。多药并存的现象很普遍。仔细研究治疗的合理性将有助于突出所涉及的问题,并有助于当局决定处方政策。
{"title":"Drug utilization in emergency medicine department at a tertiary care teaching hospital: A prospective study.","authors":"Preksha A Barot,&nbsp;Supriya D Malhotra,&nbsp;Devang A Rana,&nbsp;Varsha J Patel,&nbsp;Kamlesh P Patel","doi":"10.4103/0976-0105.121650","DOIUrl":"https://doi.org/10.4103/0976-0105.121650","url":null,"abstract":"<p><strong>Background and objectives: </strong>The practice of emergency medicine has the primary mission of evaluating, managing and providing treatment to those patients with unexpected injury or illness. Instituting appropriate therapy is necessary for safety of the patients and to decrease mortality and morbidity. The objectives were to study the drug utilization pattern and direct cost of therapy in emergency medicine department of a tertiary care teaching hospital.</p><p><strong>Materials and methods: </strong>Data of the patients admitted to emergency medicine department was collected prospectively for 48 h from the time of admission over 2 months. The prescriptions were analyzed for drug use pattern and direct cost of therapy was calculated.</p><p><strong>Results: </strong>A total of 156 patients received 1635 drugs with the mean of 9.99 ± 2.55 drugs/patient. Most common diagnosis was acute coronary syndrome 35 (21.79%). Ondansetron 135 (86.53%) was most frequently prescribed drug followed by pantoprazole 133 (85.25%) and furosemide 68 (43.58%). Amongst antimicrobials ceftriaxone 51 (32.69%) was the most commonly prescribed drug. Direct cost of treatment per patient for the first 48 h was र 4051 ± 1641.</p><p><strong>Conclusion: </strong>Ondansetron and pantoprazole were the most commonly prescribed drugs in the emergency department. However, their use in all patients was not justified. Polypharmacy was prevalent. A closer look at the rationality of therapy would help in highlighting issues involved and would be helpful to authorities in deciding prescribing policies.</p>","PeriodicalId":15046,"journal":{"name":"Journal of Basic and Clinical Pharmacy","volume":"4 4","pages":"78-81"},"PeriodicalIF":0.0,"publicationDate":"2013-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/cd/79/JBCP-4-78.PMC3979265.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32323954","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 32
Evaluation of antidiabetic prescriptions, cost and adherence to treatment guidelines: A prospective, cross-sectional study at a tertiary care teaching hospital. 评估抗糖尿病处方、费用和治疗指南的依从性:一项在三级护理教学医院进行的前瞻性横断面研究。
Pub Date : 2013-09-01 DOI: 10.4103/0976-0105.121653
Khushali G Acharya, Kartik N Shah, Nilay D Solanki, Devang A Rana

Introduction: Diabetes mellitus is on alarming rise in India. Drug utilization studies help to identify the adherence to standard treatment guidelines and to evaluate the rational drug usage.

Objective: To study prescription pattern, calculate the cost of antidiabetic drugs and to evaluate the adherence to treatment guidelines in diabetic patients attending the medicine outpatient department in a tertiary care teaching hospital.

Materials and methods: A prospective observational study was carried out for a period of 5 months. The diabetic patients who visited the medicine outdoor department were included. Demographic data and complete prescription details were recorded in the structured case record form. Cost of the drug therapy was calculated from the patient's bills. Indian Council for Medical research guidelines-2005 for diabetes management was used to evaluate the adherence.

Results: A total of 250 patients were enrolled in the study with mean age 57.91 ± 9.37. Out of 250 patients 126 (50.4%) were male and rest were female. A total of 1,391 drugs were prescribed, with mean of 5.56 ± 2.52 drugs and out of which 539 drugs were antidiabetics with mean of 2.18 ± 0.96. In monotherapy, metformin was frequently 218 (40.45%) prescribed. Glimepiride and metformin was the most frequently prescribed in 119 (76.28%) out of 156 antidiabetic drug combinations. Most commonly used drugs other than antidiabetics were aspirin 146 (18.9%) and atorvastatin 119 (15.41%). Mean cost of therapy for a month for a diabetic patient was 354.60 ± 305.72 INR. Majority 209 (83.6%) of prescriptions was in accordance to guidelines.

Conclusion: Metformin was the most frequently prescribed drug in the diabetes patient. Metformin and glimeperide being the most frequent combination used. Majority of the prescriptions followed standard guidelines.

导读:糖尿病在印度正以惊人的速度上升。药物利用研究有助于确定对标准治疗指南的依从性,并评估合理用药。目的:了解某三级教学医院内科门诊糖尿病患者的处方模式,计算降糖药费用,并评价患者对治疗指南的依从性。材料与方法:前瞻性观察研究,为期5个月。纳入到内科室外就诊的糖尿病患者。人口统计数据和完整的处方细节记录在结构化的病例记录表格中。药物治疗的费用是从病人的账单中计算出来的。采用印度医学研究委员会2005年糖尿病管理指南评估依从性。结果:共有250例患者入组,平均年龄57.91±9.37岁。250例患者中男性126例(50.4%),其余为女性。共处方药物1391种,平均(5.56±2.52)种,其中抗糖尿病药物539种,平均(2.18±0.96)种。在单药治疗中,二甲双胍的使用率高达218(40.45%)。在156种抗糖尿病药物组合中,格列美脲和二甲双胍的使用频率最高,占119种(76.28%)。除抗糖尿病药外,最常用的药物是阿司匹林146(18.9%)和阿托伐他汀119(15.41%)。1例糖尿病患者一个月的平均治疗费用为354.60±305.72印度卢比。209张(83.6%)处方符合指南要求。结论:二甲双胍是糖尿病患者最常用的处方药。二甲双胍和格列美脲是最常用的组合。大多数处方都遵循标准指南。
{"title":"Evaluation of antidiabetic prescriptions, cost and adherence to treatment guidelines: A prospective, cross-sectional study at a tertiary care teaching hospital.","authors":"Khushali G Acharya,&nbsp;Kartik N Shah,&nbsp;Nilay D Solanki,&nbsp;Devang A Rana","doi":"10.4103/0976-0105.121653","DOIUrl":"https://doi.org/10.4103/0976-0105.121653","url":null,"abstract":"<p><strong>Introduction: </strong>Diabetes mellitus is on alarming rise in India. Drug utilization studies help to identify the adherence to standard treatment guidelines and to evaluate the rational drug usage.</p><p><strong>Objective: </strong>To study prescription pattern, calculate the cost of antidiabetic drugs and to evaluate the adherence to treatment guidelines in diabetic patients attending the medicine outpatient department in a tertiary care teaching hospital.</p><p><strong>Materials and methods: </strong>A prospective observational study was carried out for a period of 5 months. The diabetic patients who visited the medicine outdoor department were included. Demographic data and complete prescription details were recorded in the structured case record form. Cost of the drug therapy was calculated from the patient's bills. Indian Council for Medical research guidelines-2005 for diabetes management was used to evaluate the adherence.</p><p><strong>Results: </strong>A total of 250 patients were enrolled in the study with mean age 57.91 ± 9.37. Out of 250 patients 126 (50.4%) were male and rest were female. A total of 1,391 drugs were prescribed, with mean of 5.56 ± 2.52 drugs and out of which 539 drugs were antidiabetics with mean of 2.18 ± 0.96. In monotherapy, metformin was frequently 218 (40.45%) prescribed. Glimepiride and metformin was the most frequently prescribed in 119 (76.28%) out of 156 antidiabetic drug combinations. Most commonly used drugs other than antidiabetics were aspirin 146 (18.9%) and atorvastatin 119 (15.41%). Mean cost of therapy for a month for a diabetic patient was 354.60 ± 305.72 INR. Majority 209 (83.6%) of prescriptions was in accordance to guidelines.</p><p><strong>Conclusion: </strong>Metformin was the most frequently prescribed drug in the diabetes patient. Metformin and glimeperide being the most frequent combination used. Majority of the prescriptions followed standard guidelines.</p>","PeriodicalId":15046,"journal":{"name":"Journal of Basic and Clinical Pharmacy","volume":"4 4","pages":"82-7"},"PeriodicalIF":0.0,"publicationDate":"2013-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4103/0976-0105.121653","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32323955","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 53
Antidiabetic and antihyperlipidemic effects of an ethanolic extract of the whole plant of Tridax procumbens (Linn.) in streptozotocin-induced diabetic rats. 原甘松全株乙醇提取物对链脲佐菌素诱导的糖尿病大鼠的降糖和降血脂作用。
Pub Date : 2013-09-01 DOI: 10.4103/0976-0105.121655
Ramesh R Petchi, S Parasuraman, C Vijaya

Objective: To study the antidiabetic and antihyperlipidemic effects of an ethanolic extract of the whole plant of Tridax procumbens (Asteraceae) in streptozotocin-induced diabetic rats.

Materials and methods: The whole plant of T. procumbens was collected in different regions of Madurai districts, Tamil Nadu. The air dried whole plant of T. procumbens was extracted with ethanol (95%) in a Soxhlet apparatus for 72 h. Diabetes was induced in male Wistar rats by streptozotocin (50 mg/jk, i.p.) and nicotinamide (120 mg/kg, i.p) injection. The dry mass of the extract was used for preliminary phytochemical and pharmacological analysis. Diabetic rats were treated with glibenclamide (0.25 mg/kg, p.o.) or T. procumbens extract (250 and 500 mg/k, p.o.) for 21 consecutive days. The blood samples were collected at regular intervals to access hypoglycemic effect of an ethanolic extract of the whole plant of T. procumbens. At the end of the experiment, serum lipid profile and liver enzymes levels were analyzed for all the experimental animals and compared with diabetic control.

Results: The preliminary phytochemical analysis of an ethanolic extract of the whole plant of T. procumbens indicated the presence of alkaloids, tannins, flavonoids, saponins, and phenolic compounds. The ethanolic extract of the whole plant of T. procumbens at 250 and 500 mg/kg has significant antidiabetic and antihyperlipidemic activities. The diabetic control animals exhibited a significant decrease in body weight compared with control animals. T. procumbens inhibited streptozotocin-induced weight loss and significantly alter the lipid levels.

Conclusion: The ethanolic extract of the whole plant of T. procumbens showed significant antidiabetic and antihyperlipidemic activities against streptozotocin-induced diabetes in rats.

目的:研究原楚梅全株乙醇提取物对链脲佐菌素诱导的糖尿病大鼠的降糖和降血脂作用。材料与方法:在泰米尔纳德邦马杜赖地区的不同地区采集了全株玉米。用乙醇(95%)在索氏装置中风干的原棘全株提取72 h,用链脲佐菌素(50 mg/jk,灌胃)和烟酰胺(120 mg/kg,灌胃)诱导雄性Wistar大鼠糖尿病。提取液的干质量用于初步的植物化学和药理分析。用格列本脲(0.25 mg/kg, p.o.)或原藜提取物(250和500 mg/k, p.o.)连续治疗糖尿病大鼠21 d。定期采集血液样本,以获得整株赤豆的乙醇提取物的降糖效果。实验结束时,分析所有实验动物的血脂和肝酶水平,并与糖尿病对照组进行比较。结果:经初步植物化学分析发现,原丘茴香全株乙醇提取物中含有生物碱、单宁、黄酮类化合物、皂苷和酚类化合物。250mg /kg和500mg /kg的原棘全株乙醇提取物具有显著的抗糖尿病和降血脂活性。与对照组动物相比,糖尿病对照组动物的体重明显下降。原甘菊抑制链脲佐菌素引起的体重减轻,并显著改变脂质水平。结论:原春草全株乙醇提取物对链脲佐菌素诱导的糖尿病大鼠具有明显的降糖、降血脂作用。
{"title":"Antidiabetic and antihyperlipidemic effects of an ethanolic extract of the whole plant of Tridax procumbens (Linn.) in streptozotocin-induced diabetic rats.","authors":"Ramesh R Petchi,&nbsp;S Parasuraman,&nbsp;C Vijaya","doi":"10.4103/0976-0105.121655","DOIUrl":"https://doi.org/10.4103/0976-0105.121655","url":null,"abstract":"<p><strong>Objective: </strong>To study the antidiabetic and antihyperlipidemic effects of an ethanolic extract of the whole plant of Tridax procumbens (Asteraceae) in streptozotocin-induced diabetic rats.</p><p><strong>Materials and methods: </strong>The whole plant of T. procumbens was collected in different regions of Madurai districts, Tamil Nadu. The air dried whole plant of T. procumbens was extracted with ethanol (95%) in a Soxhlet apparatus for 72 h. Diabetes was induced in male Wistar rats by streptozotocin (50 mg/jk, i.p.) and nicotinamide (120 mg/kg, i.p) injection. The dry mass of the extract was used for preliminary phytochemical and pharmacological analysis. Diabetic rats were treated with glibenclamide (0.25 mg/kg, p.o.) or T. procumbens extract (250 and 500 mg/k, p.o.) for 21 consecutive days. The blood samples were collected at regular intervals to access hypoglycemic effect of an ethanolic extract of the whole plant of T. procumbens. At the end of the experiment, serum lipid profile and liver enzymes levels were analyzed for all the experimental animals and compared with diabetic control.</p><p><strong>Results: </strong>The preliminary phytochemical analysis of an ethanolic extract of the whole plant of T. procumbens indicated the presence of alkaloids, tannins, flavonoids, saponins, and phenolic compounds. The ethanolic extract of the whole plant of T. procumbens at 250 and 500 mg/kg has significant antidiabetic and antihyperlipidemic activities. The diabetic control animals exhibited a significant decrease in body weight compared with control animals. T. procumbens inhibited streptozotocin-induced weight loss and significantly alter the lipid levels.</p><p><strong>Conclusion: </strong>The ethanolic extract of the whole plant of T. procumbens showed significant antidiabetic and antihyperlipidemic activities against streptozotocin-induced diabetes in rats.</p>","PeriodicalId":15046,"journal":{"name":"Journal of Basic and Clinical Pharmacy","volume":"4 4","pages":"88-92"},"PeriodicalIF":0.0,"publicationDate":"2013-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4103/0976-0105.121655","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32323956","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Optimization of liposomal encapsulation for ceftazidime for developing a potential eye drop formulation. 头孢他啶脂质体包封工艺优化制备一种潜在滴眼液配方。
Pub Date : 2013-06-01 DOI: 10.4103/0976-0105.118810
Chamari Wijesooriya, Marianna Budai, Lívia Budai, Magdolna E Szilasi, Ilona Petrikovics

Ceftazidime is a broad spectrum third generation cephalosporin antibiotic which is effective mainly against Gram-negative bacteria such as Pseudomonas aeruginosa, Acinetobacter and Enterobacteriaceae, the pathogens which most often cause ophthalmological infections. Unlike other commonly used beta lactam antibiotics, ceftazidime is resistant to several types of beta lactamases (e.g., TEM, SHV and PSE-1). Because of these advantages, ceftazidime is used in the treatment of eye infections. However, ceftazidime undergoes rapid degradation in aqueous solutions therefore eye drops containing ceftazidime in aqueous solutions are not commercially manufactured. In the present study, liposomal encapsulations of ceftazidime with various lipid compositions, hydrating solutions and pH-values have been studied in order to optimize liposomal composition for a potential eye drop formulation.

头孢他啶是广谱第三代头孢菌素类抗生素,主要作用于革兰氏阴性菌,如铜绿假单胞菌、不动杆菌和肠杆菌科,这些病原体最常引起眼部感染。与其他常用的β -内酰胺类抗生素不同,头孢他啶对几种β -内酰胺酶(如TEM、SHV和PSE-1)具有耐药性。由于这些优点,头孢他啶被用于治疗眼部感染。然而,头孢他啶在水溶液中会迅速降解,因此,含头孢他啶水溶液的滴眼液不能商业化生产。在本研究中,研究了头孢他啶与不同脂质组成、水合溶液和ph值的脂质体包封,以优化一种潜在滴眼液配方的脂质体组成。
{"title":"Optimization of liposomal encapsulation for ceftazidime for developing a potential eye drop formulation.","authors":"Chamari Wijesooriya,&nbsp;Marianna Budai,&nbsp;Lívia Budai,&nbsp;Magdolna E Szilasi,&nbsp;Ilona Petrikovics","doi":"10.4103/0976-0105.118810","DOIUrl":"https://doi.org/10.4103/0976-0105.118810","url":null,"abstract":"<p><p>Ceftazidime is a broad spectrum third generation cephalosporin antibiotic which is effective mainly against Gram-negative bacteria such as Pseudomonas aeruginosa, Acinetobacter and Enterobacteriaceae, the pathogens which most often cause ophthalmological infections. Unlike other commonly used beta lactam antibiotics, ceftazidime is resistant to several types of beta lactamases (e.g., TEM, SHV and PSE-1). Because of these advantages, ceftazidime is used in the treatment of eye infections. However, ceftazidime undergoes rapid degradation in aqueous solutions therefore eye drops containing ceftazidime in aqueous solutions are not commercially manufactured. In the present study, liposomal encapsulations of ceftazidime with various lipid compositions, hydrating solutions and pH-values have been studied in order to optimize liposomal composition for a potential eye drop formulation. </p>","PeriodicalId":15046,"journal":{"name":"Journal of Basic and Clinical Pharmacy","volume":"4 3","pages":"73-5"},"PeriodicalIF":0.0,"publicationDate":"2013-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4103/0976-0105.118810","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32323952","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
An interventional study on intensive care unit drug therapy assessment in a rural district hospital in India. 印度农村地区医院重症监护病房药物治疗评估的介入研究
Pub Date : 2013-06-01 DOI: 10.4103/0976-0105.118801
Priyanka Tejashwani Pichala, Bharani Mukkillapati Kumar, Seeba Zachariah, Dixon Thomas, Laura Saunchez, Alvarez-Uria Gerardo

Background: Intensive care unit is a potential area for drug-related problems. As many of the patients treated are complex patients, clinical pharmacy intervention could find drug therapy problems.

Materials and methods: Drug information liaisons daily attended ward rounds with intensivists and screened the patient for drug therapy assessment using the American Society for Health-System Pharmacists clinical skills competition DTA format. This was a prospective study done for 6 months from August 2012 to January 2013. Simple statistics were used to tabulate the drug-related problems assessed.

Results: A total of 72 patients were screened for drug therapy problems, for which 947 drug doses were prescribed in the study period. The total number of prescriptions was 148. The average number of drugs per prescription was 6.39 and the average number of drugs per patient was 13.15. A total of 243 problems were identified; on an average, 1.67 problems were present per prescription. The total number of drug interactions identified was N = 192 (78.2%); majority of them (61.4%) were of type C (not serious). So, 55.73% of them were monitored and not stopped or substituted. The second type of problem was a correlation between drug therapy and medical problem (7.4%). Appropriate drug selection and drug regimen was the third problem, and the adverse drug reactions and therapeutic duplications accounted for approximately 2% of the drug-related problems identified.

Conclusion: Drug interactions constituted the major problem of ICUs, but not many were serious or significant. Consensus in assessment of drug-related problems and convincing intensivists with good quality evidences are required for better acceptance of interventions.

背景:重症监护病房是药物相关问题的潜在领域。由于治疗的患者多为复杂患者,临床药学干预可发现药物治疗问题。材料和方法:药物信息联络员每天与重症监护医师一起参加查房,并使用美国卫生系统药剂师临床技能竞赛DTA格式筛选患者进行药物治疗评估。这是一项为期6个月的前瞻性研究,从2012年8月到2013年1月。使用简单的统计数据将评估的药物相关问题制成表格。结果:共筛查出72例患者的药物治疗问题,研究期间共开具了947剂药物处方。处方总数为148张。每张处方平均药品数量为6.39种,每位患者平均药品数量为13.15种。共发现243个问题;平均来看,每份处方中存在1.67个问题。鉴定出的药物相互作用总数为N = 192 (78.2%);绝大多数(61.4%)为C型(不严重)。因此,55.73%的人被监控,没有停止或替换。第二类问题是药物治疗与医疗问题之间的相关性(7.4%)。适当的药物选择和药物方案是第三个问题,药物不良反应和治疗重复约占确定的药物相关问题的2%。结论:药物相互作用是icu的主要问题,但严重和显著的并不多。为了更好地接受干预措施,需要在评估药物相关问题方面达成共识,并以高质量的证据说服重症监护医生。
{"title":"An interventional study on intensive care unit drug therapy assessment in a rural district hospital in India.","authors":"Priyanka Tejashwani Pichala,&nbsp;Bharani Mukkillapati Kumar,&nbsp;Seeba Zachariah,&nbsp;Dixon Thomas,&nbsp;Laura Saunchez,&nbsp;Alvarez-Uria Gerardo","doi":"10.4103/0976-0105.118801","DOIUrl":"https://doi.org/10.4103/0976-0105.118801","url":null,"abstract":"<p><strong>Background: </strong>Intensive care unit is a potential area for drug-related problems. As many of the patients treated are complex patients, clinical pharmacy intervention could find drug therapy problems.</p><p><strong>Materials and methods: </strong>Drug information liaisons daily attended ward rounds with intensivists and screened the patient for drug therapy assessment using the American Society for Health-System Pharmacists clinical skills competition DTA format. This was a prospective study done for 6 months from August 2012 to January 2013. Simple statistics were used to tabulate the drug-related problems assessed.</p><p><strong>Results: </strong>A total of 72 patients were screened for drug therapy problems, for which 947 drug doses were prescribed in the study period. The total number of prescriptions was 148. The average number of drugs per prescription was 6.39 and the average number of drugs per patient was 13.15. A total of 243 problems were identified; on an average, 1.67 problems were present per prescription. The total number of drug interactions identified was N = 192 (78.2%); majority of them (61.4%) were of type C (not serious). So, 55.73% of them were monitored and not stopped or substituted. The second type of problem was a correlation between drug therapy and medical problem (7.4%). Appropriate drug selection and drug regimen was the third problem, and the adverse drug reactions and therapeutic duplications accounted for approximately 2% of the drug-related problems identified.</p><p><strong>Conclusion: </strong>Drug interactions constituted the major problem of ICUs, but not many were serious or significant. Consensus in assessment of drug-related problems and convincing intensivists with good quality evidences are required for better acceptance of interventions.</p>","PeriodicalId":15046,"journal":{"name":"Journal of Basic and Clinical Pharmacy","volume":"4 3","pages":"64-7"},"PeriodicalIF":0.0,"publicationDate":"2013-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4103/0976-0105.118801","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32323950","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 17
期刊
Journal of Basic and Clinical Pharmacy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1